Bigfoot Biomedical, a Milpitas, CA-based company dedicated to health outcomes for people with insulin-requiring diabetes, secured new debt and equity financing of up to $57m from Madryn Asset Management.
The company intends to use the proceeds of the investment for commercialization of its Bigfoot Unity™ Diabetes Management Program.
Led by Jeffrey Brewer, CEO, Bigfoot Biomedical partners with health care providers to deliver connected, and comprehensive solutions to support the treatment of Type 1 and Type 2 diabetes.
Currently, the company is anticipating FDA clearance of its Bigfoot Unity System, which features smart pen caps that provide insulin dose decision support and enable patients to follow their doctor’s instructions in simple way.
FinSMEs
19/03/2021